Conference Proceedings

Risk and timing of clinical events according to diabetic status of patients treated with Everolimus-Eluting Bioresorbable Vascular Scaffolds vs. Everolimus-Eluting stent: 2-Year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials

Carlos Campos, Alexandre Abizaid, Adriano Caixeta, Antonio Bartorelli, Robert Whitbourn, Marco Perin

Catheterization and Cardiovascular Interventions | ELSEVIER SCIENCE INC | Published : 2016